Topical beta-blockers: no increase in cardiovascular and respiratory risk

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1815卷 / 1期
关键词：
D O I：
10.1007/s40278-020-81337-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [1] CARDIOVASCULAR EFFECTS OF TOPICAL BETA-BLOCKERS DURING EXERCISE
    ATKINS, JM
    PUGH, BR
    TIMEWELL, RM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1985, 99 (02) : 173 - 175
  • [2] DO BETA-BLOCKERS INCREASE THE RISK OF IMMUNOTHERAPY
    YOUNG, C
    TOOGOOD, JH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (01) : 225 - 225
  • [3] OPHTHALMIC BETA-BLOCKERS AND CARDIOVASCULAR RISK IN THE ELDERLY
    MONANE, M
    BOHN, R
    GURWITZ, JH
    GLYNN, RJ
    CHOODNOVSKIY, I
    AVORN, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 191 - 191
  • [4] THE TOXICITY OF TOPICAL OPHTHALMIC BETA-BLOCKERS
    NOVACK, GD
    LEOPOLD, IH
    JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY, 1987, 6 (04): : 283 - 297
  • [5] Topical beta-blockers and wound healing
    Herskovitz, I.
    Jaller, J.
    Kirsner, R.
    Lev-Tov, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S249 - S249
  • [6] Uveitis associated with topical beta-blockers
    Beck, RW
    Moke, P
    Blair, RC
    Nissenbaum, R
    ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (10) : 1181 - 1182
  • [7] Topical beta-blockers in dermatologic therapy
    Filoni, Angela
    Ambrogio, Francesca
    De Marco, Aurora
    Pacifico, Alessia
    Bonamonte, Domenico
    DERMATOLOGIC THERAPY, 2021, 34 (04)
  • [8] Association between topical beta-blockers and risks of cardiovascular and respiratory disease in patients with glaucoma: a retrospective cohort study
    Chen, Hsin-Yi
    Huang, Wei-Cheng
    Lin, Cheng-Li
    Kao, Chia-Hung
    BMJ OPEN, 2020, 10 (07): : e034361
  • [9] EFFECTS OF BETA-BLOCKERS AND OTHER ANTIHYPERTENSIVE DRUGS ON CARDIOVASCULAR RISK
    CHOBANIAN, AV
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (13): : F48 - F52
  • [10] TOPICAL OPHTHALMIC BETA-BLOCKERS - A COMPARATIVE REVIEW
    ZIMMERMAN, TJ
    JOURNAL OF OCULAR PHARMACOLOGY, 1993, 9 (04): : 373 - 384
12345